TGM2 and cancer: Although the majority of studies have linked an increase in TG2 with the survival, motility, invasion and drug/chemotherapy resistance of cancer, the role of the alternative splice forms has not been fully understood; however, dysregulation of the alternative splice forms in different cancer types has been reported [26].